Creon Capsule, Delayed Release
Product Images NDC 0032-0045

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Creon (NDC 0032-0045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 01

This is a prescription medication called Pancrelipase, also known as CREON, used to improve digestion in individuals with certain pancreatic conditions. The rest of the text seems to be inaccurate output and cannot provide any useful information.*

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 02

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 03

This is a medication label for Creon, which contains 250 delayed-release capsules with each capsule containing 6,000 USP units of lipase, 19,000 USP units of protease and 30,000 USP units of amylase. The medication guide should be given to the patient and the bottle must be kept tightly closed and protected from moisture. The medication should not be crushed or chewed. The recommended dosage is not available. Abbe Inc. is the manufacturer of Creon.*

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 04

This text seems to be a warning label for a medication called CREON. It advises users not to crush or chew the drug and provides recommended dosage and storage instructions. The medication is a pancrelipase and contains lipase and amylase. The label is produced by AbbVie Inc, a pharmaceutical company located in North Chicago.*

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 05

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 06

The text describes a medication called CREON, which is contained in delayed-release capsules that should not be crushed or chewed. The capsules contain pancrelipase in enteric-coated spheres and are used to aid in digestion. The capsules come in a bottle and should be stored at room temperature and protected from moisture. The medication guide should be given to each patient. The label includes the company name Abbvie Inc. and a warning not to use the medication if the seal is broken or missing. The text also includes dosage instructions, prescription information, and licensing information.*

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 07

FDA Label Image

Creon Pancrelipase Delayed Release Capsules Spl 08

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.